Risk factors for cataract in retinoblastoma management

AimsTo investigate the risk factors for cataract following eye-preserving therapies for retinoblastoma.MethodsThis retrospective, single-centre cohort study included patients diagnosed with retinoblastoma receiving eye-preserving therapies between January 2017 and June 2021. Cataract by the end of t...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	British journal of ophthalmology 2023-04, Vol.108 (4), p.571-577
Hauptverfasser:	Jia, Shichong, Wen, Xuyang, Yu, Jie, Zhou, Min, Yang, Ludi, Feng, Yiyi, He, Xiaoyu, Jia, Renbing, Fan, Jiayan, Fan, Xianqun
Format:	Artikel
Sprache:	eng
Schlagworte:	Antineoplastic Combined Chemotherapy Protocols - adverse effects Carboplatin - therapeutic use Cataract - chemically induced Cataract - drug therapy Cataract - epidemiology Cataracts Chemotherapy Child health (paediatrics) Cohort Studies Cryotherapy Drug dosages Humans Infant Infusions, Intra-Arterial - adverse effects Melphalan Ocular oncology Patients Pediatrics Radiation therapy Retina Retinal Neoplasms - diagnosis Retinoblastoma Retinoblastoma - diagnosis Retrospective Studies Risk Factors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!